Sanofi-Aventis said it will acquire a majority stake in Indian vaccines maker Shantha Biotechnics in an effort to bolster its vaccines portfolio, and expand into emerging markets., more
Sunday, August 2, 2009
Subscribe to:
Post Comments (Atom)

No comments:
Post a Comment